Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?

Xavier Durrmeyer, Shushanik Hovhannisyan, Yves Médard et al. · 2010

Read Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants? by Xavier Durrmeyer, Shushanik Hovhannisyan, Yves Médard et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012329.txt.

Description

Xavier Durrmeyer, Shushanik Hovhannisyan, Yves Médard, and co-authors asked if gene variants explain ibuprofen failures in preterm babies, in PLOS ONE in 2010. Very early babies often keep a fetal blood vessel open. That vessel should close soon after birth. Ibuprofen is the standard drug to close it. Yet it fails in up to four babies in ten. Two liver enzymes break the drug down. The genes for those enzymes vary between people.

Testing those variants in very preterm infants checks one clear idea. Slow or fast drug handling may decide whose vessel closes. If genes explain the failures, doctors could pick the dose by a quick test. They could also switch drugs at once instead of losing days. In care of newborns, days are not a small currency.

Catalog record

CREATORXavier Durrmeyer, Shushanik Hovhannisyan, Yves Médard et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012329

Browse the full library · About the Tower of Babel